Cargando…

All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease

AIMS: The rate of all-cause mortality is twofold higher in type 2 diabetes than in the general population. Being able to identify patients with the highest risk from the very beginning of the disease would help tackle this burden. METHODS: We tested whether ENFORCE, an established prediction model o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Copetti, Massimiliano, Biancalana, Edoardo, Fontana, Andrea, Parolini, Federico, Garofolo, Monia, Lamacchia, Olga, De Cosmo, Salvatore, Trischitta, Vincenzo, Solini, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164049/ https://www.ncbi.nlm.nih.gov/pubmed/34050821 http://dx.doi.org/10.1007/s00592-021-01746-2

Ejemplares similares

Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
por: Pacilli, Antonio, et al.
Publicado: (2015)

Phenotyping individuals with newly-diagnosed type 2 diabetes at risk for all-cause mortality: a single centre observational, prospective study
por: Biancalana, Edoardo, et al.
Publicado: (2020)

Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes
por: De Cosmo, Salvatore, et al.
Publicado: (2013)

Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data
por: Fontana, Andrea, et al.
Publicado: (2017)

Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study
por: Biancalana, Edoardo, et al.
Publicado: (2020)

Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes
por: Ortega Moreno, Lorena, et al.
Publicado: (2015)

Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis
por: Fontana, Andrea, et al.
Publicado: (2015)

Normal Versus Slowly Processed Pasta and Post-Prandial Glucose Homeostasis in Healthy Subjects: A Pilot Study
por: Mengozzi, Alessandro, et al.
Publicado: (2021)

The Adiponectin Paradox for All-Cause and Cardiovascular Mortality
por: Menzaghi, Claudia, et al.
Publicado: (2018)

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes
por: Prudente, Sabrina, et al.
Publicado: (2015)

Erratum. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. Diabetes 2018;67:12–22
por: Menzaghi, Claudia, et al.
Publicado: (2018)

Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes
por: Ortega Moreno, Lorena, et al.
Publicado: (2016)

Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
por: Orsi, Emanuela, et al.
Publicado: (2022)

Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes
por: Menzaghi, Claudia, et al.
Publicado: (2013)

Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes
por: Trischitta, Vincenzo, et al.
Publicado: (2023)

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study
por: Solini, Anna, et al.
Publicado: (2019)

Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
por: Penno, Giuseppe, et al.
Publicado: (2021)

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus
por: Ludovico, Ornella, et al.
Publicado: (2015)

Serum Resistin and Glomerular Filtration Rate in Patients with Type 2 Diabetes
por: Moreno, Lorena Ortega, et al.
Publicado: (2015)

High exposure to phthalates is associated with HbA1(c) worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study
por: Mengozzi, Alessandro, et al.
Publicado: (2022)

SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all‐cause mortality, in Caucasians with type 2 diabetes: A 13‐year observational study
por: Dardano, Angela, et al.
Publicado: (2022)

Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study
por: Garofolo, Monia, et al.
Publicado: (2020)

Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study
por: Biancalana, Edoardo, et al.
Publicado: (2021)

Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report
por: Biancalana, Edoardo, et al.
Publicado: (2023)

Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study
por: Garofolo, Monia, et al.
Publicado: (2019)

Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects
por: Biancalana, Edoardo, et al.
Publicado: (2023)

Identifying Predictors Associated with Risk of Death or Admission to Intensive Care Unit in Internal Medicine Patients with Sepsis: A Comparison of Statistical Models and Machine Learning Algorithms
por: Mirijello, Antonio, et al.
Publicado: (2023)

Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism
por: Menzaghi, Claudia, et al.
Publicado: (2014)

Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
por: Orsi, Emanuela, et al.
Publicado: (2022)

Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141
por: Garofolo, Monia, et al.
Publicado: (2021)

The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage
por: Rossi, Chiara, et al.
Publicado: (2022)

Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes
por: Bertoccini, Laura, et al.
Publicado: (2018)

Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals
por: Menzaghi, Claudia, et al.
Publicado: (2017)

Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study
por: Sacchetta, Luca, et al.
Publicado: (2022)

Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
por: Penno, Giuseppe, et al.
Publicado: (2020)

Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT
por: De Cosmo, Salvatore, et al.
Publicado: (2009)

Educational gradients in all-cause mortality in two cohorts in the Czech Republic during the early stage of the postcommunist transition
por: Pauls, Ceciel, et al.
Publicado: (2022)

Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study
por: Orsi, Emanuela, et al.
Publicado: (2021)

Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy
por: Mannucci, Edoardo, et al.
Publicado: (2020)

The Gamma Gap and All-Cause Mortality
por: Juraschek, Stephen P., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_941a81sfeiebon3mkbm0p3i5iq